WINTON GROUP Ltd Has $806,000 Stock Position in Schrödinger, Inc. (NASDAQ:SDGR)

WINTON GROUP Ltd boosted its stake in Schrödinger, Inc. (NASDAQ:SDGR) by 89.3% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,654 shares of the company’s stock after purchasing an additional 5,027 shares during the quarter. WINTON GROUP Ltd’s holdings in Schrödinger were worth $806,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Stephens Inc. AR acquired a new position in Schrödinger during the first quarter valued at approximately $29,000. Sandy Spring Bank increased its stake in shares of Schrödinger by 135.3% in the 2nd quarter. Sandy Spring Bank now owns 400 shares of the company’s stock valued at $30,000 after purchasing an additional 230 shares during the last quarter. O Shaughnessy Asset Management LLC acquired a new position in shares of Schrödinger during the 2nd quarter worth $66,000. Lazard Asset Management LLC lifted its position in shares of Schrödinger by 23.6% during the 1st quarter. Lazard Asset Management LLC now owns 999 shares of the company’s stock worth $76,000 after buying an additional 191 shares during the last quarter. Finally, Guardian Wealth Advisors LLC acquired a new stake in Schrödinger in the first quarter valued at about $105,000. 55.29% of the stock is owned by institutional investors and hedge funds.

SDGR opened at $62.42 on Friday. Schrödinger, Inc. has a fifty-two week low of $46.27 and a fifty-two week high of $117.00. The company’s 50 day moving average price is $63.74 and its two-hundred day moving average price is $70.31. The firm has a market capitalization of $4.42 billion, a price-to-earnings ratio of -100.68 and a beta of 1.00.

Schrödinger (NASDAQ:SDGR) last issued its quarterly earnings data on Thursday, August 12th. The company reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.29) by ($0.20). Schrödinger had a negative return on equity of 6.73% and a negative net margin of 34.75%. As a group, research analysts expect that Schrödinger, Inc. will post -1.2 EPS for the current fiscal year.

SDGR has been the topic of a number of research analyst reports. Craig Hallum began coverage on shares of Schrödinger in a research note on Tuesday, May 25th. They issued a “buy” rating and a $85.00 price target on the stock. Morgan Stanley raised shares of Schrödinger from an “equal weight” rating to an “overweight” rating and set a $82.00 target price on the stock in a research note on Wednesday, September 1st. Finally, Zacks Investment Research cut Schrödinger from a “buy” rating to a “hold” rating in a research note on Saturday, August 14th. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Buy” and an average price target of $83.33.

In other Schrödinger news, insider Robert Lorne Abel sold 15,602 shares of the company’s stock in a transaction on Monday, June 21st. The shares were sold at an average price of $74.16, for a total transaction of $1,157,044.32. Following the sale, the insider now owns 7,814 shares of the company’s stock, valued at $579,486.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Karen Akinsanya sold 1,394 shares of the business’s stock in a transaction dated Wednesday, September 15th. The shares were sold at an average price of $61.13, for a total value of $85,215.22. Following the completion of the transaction, the insider now directly owns 1,394 shares in the company, valued at $85,215.22. The disclosure for this sale can be found here. Insiders sold a total of 635,218 shares of company stock worth $47,232,547 in the last quarter. Corporate insiders own 5.00% of the company’s stock.

About Schrödinger

Schrödinger, Inc provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates through two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries.

See Also: What is included in the gross domestic product?

Want to see what other hedge funds are holding SDGR? Visit to get the latest 13F filings and insider trades for Schrödinger, Inc. (NASDAQ:SDGR).

Institutional Ownership by Quarter for Schrödinger (NASDAQ:SDGR)

Receive News & Ratings for Schrödinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrödinger and related companies with's FREE daily email newsletter.